Proton beam radiation aims to spare healthy tissue in breast cancer treatment

NCT ID NCT01245712

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This phase II trial is testing a type of radiation called proton beam therapy for women with early-stage breast cancer (stage 0 to II). The goal is to see if this targeted approach can kill cancer cells while causing less damage to normal tissue, leading to fewer side effects and better cosmetic outcomes. About 200 women will receive the treatment and be followed for side effects and breast appearance.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Proton beam radiation therapy
What this could lead to
If successful, this could offer a more precise radiation option for early breast cancer with fewer side effects and better cosmetic results.
What could go wrong
This is a phase II trial with 200 participants, so results are still preliminary. It may not prove better than standard radiation, and some skin reactions or other side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.